ARYZTA AG Logo

ARYZTA AG

ISIN

CH0043238366

Ticker

ARYN

Sector

Consumer Staples

Sub-Industry

Agricultural Products & Services

Country

Switzerland

Year Founded

About ARYZTA AG

Company Description

ARYZTA is an organization with unparalleled capabilities in the baking industry. Our delicious foods include artisan breads, pastries, cookies, donuts, muffins, buns and so much more! It all begins with the finest ingredients—along with bakers and chefs whose top priorities are great taste, consistency, and creating memorable foods for our customers.

ARYZTA is an international business dedicated local market needs that empowers local leadership teams and creates value for our customers.

This multi-local approach allows us to have very simple structure, empowers fast decision making to address our local customers’ needs. It means we become closer to our customers with shorter supply chains and accelerated innovation response times.

This improves the local management’s engagement and understanding of our clients and drives deeper customer relationships.

Served Area

Worldwide

Headquarters

Ifangstrasse 9
8952, Schlieren
Switzerland

Insider Trades

Date Trading entity / Person Association Trade type Volume
14.05.2024 None Non-Executive member Buy CHF 17,545.71
29.12.2023 None Non-Executive member Buy CHF 77,600.00
08.12.2023 None Non-Executive member Buy CHF 102,691.85
29.11.2023 None Non-Executive member Buy CHF 319,145.00
29.11.2023 None Executive member Buy CHF 253,503.45
16.10.2023 None Non-Executive member Sell CHF 1,287,742.95
13.10.2023 None Non-Executive member Sell CHF 967,309.58
17.06.2022 None Non-Executive member Buy CHF 120,000.00
17.06.2022 None Executive member Buy CHF 100,335.27
08.03.2022 None Non-Executive member Buy CHF 220,546.29

Capital Markets Information

ISIN

CH0043238366

LEI

549300W2PUDQQVRD8W85

Listed Stock Exchange

SIX Swiss Exchange

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.